Hansa Biopharma AB (0RC7.LSE) Q3 2024 Earnings

18JulConfirmed
Q3 2024
-3.28
-3.11
-2.94
-2.76

Details

Expected EPS
-2.764588253233347
Actual EPS
-3.2812723053
Surprise EPS
-0.52
Surprise Percent
+18.69%

Description

Hansa Biopharma AB (0RC7.LSE) has reported earnings of -3.2812723053 per share for Q3 2024.

0 Comments

Share your thoughts